Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal - PubMed (original) (raw)

Comparative Study

Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal

P P Lee et al. J Virol. 1994 Oct.

Abstract

Lentiviruses, such as human immunodeficiency virus type 1 (HIV-1), assemble at and bud through the cytoplasmic membrane. Both the matrix (MA) domain of Gag and its amino-terminal myristylation have been implicated in these processes. We have created HIV-1 proviruses lacking the entire matrix domain of gag which either lack or contain an amino-terminal myristate addition sequence at the beginning of the capsid domain. Myristate- and matrix-deficient [myr(-)MA(-)] viruses produced after transient transfection are still able to assemble into particles, although the majority do not form at the plasma membrane or bud efficiently. Myristylation of the amino terminus of the truncated Gag precursor permits a much more efficient release of the mutant virions. While myr(-)MA(-) particles were inefficient in proteolytic processing of the Gag precursor, myristylation enabled efficient proteolysis of the mutant Gag. All matrix-deficient viruses are noninfectious. Particles produced by matrix-deficient mutants contain low levels of glycoproteins, indicating the importance of matrix in either incorporation or stable retention of Env. Since matrix-deficient viruses contain a normal complement of viral genomic RNA, a role for MA in genomic incorporation can be excluded. Contrary to previous reports, the HIV-1 genome does not require sequences between the 5' splice donor site and the gag start codon for efficient packaging.

PubMed Disclaimer

Cited by

Cytoplasmic CPSF6 Regulates HIV-1 Capsid Trafficking and Infection in a Cyclophilin A-Dependent Manner.
Zhong Z, Ning J, Boggs EA, Jang S, Wallace C, Telmer C, Bruchez MP, Ahn J, Engelman AN, Zhang P, Watkins SC, Ambrose Z. Zhong Z, et al. mBio. 2021 Mar 23;12(2):e03142-20. doi: 10.1128/mBio.03142-20. mBio. 2021. PMID: 33758083 Free PMC article.
Structural and Molecular Determinants of Membrane Binding by the HIV-1 Matrix Protein.
Mercredi PY, Bucca N, Loeliger B, Gaines CR, Mehta M, Bhargava P, Tedbury PR, Charlier L, Floquet N, Muriaux D, Favard C, Sanders CR, Freed EO, Marchant J, Summers MF. Mercredi PY, et al. J Mol Biol. 2016 Apr 24;428(8):1637-55. doi: 10.1016/j.jmb.2016.03.005. Epub 2016 Mar 16. J Mol Biol. 2016. PMID: 26992353 Free PMC article.
Deletions in the fifth alpha helix of HIV-1 matrix block virus release.
Sanford B, Li Y, Maly CJ, Madson CJ, Chen H, Zhou Y, Belshan M. Sanford B, et al. Virology. 2014 Nov;468-470:293-302. doi: 10.1016/j.virol.2014.08.017. Epub 2014 Sep 15. Virology. 2014. PMID: 25217711 Free PMC article.
Roles played by acidic lipids in HIV-1 Gag membrane binding.
Olety B, Ono A. Olety B, et al. Virus Res. 2014 Nov 26;193:108-15. doi: 10.1016/j.virusres.2014.06.015. Epub 2014 Jul 3. Virus Res. 2014. PMID: 24998886 Free PMC article. Review.
Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus.
Akiyama H, Miller C, Patel HV, Hatch SC, Archer J, Ramirez NG, Gummuluru S. Akiyama H, et al. J Virol. 2014 Aug;88(16):8813-25. doi: 10.1128/JVI.00992-14. Epub 2014 May 28. J Virol. 2014. PMID: 24872578 Free PMC article.

References

1. Annu Rev Biochem. 1988;57:69-99 - PubMed
1. Anal Biochem. 1987 Apr;162(1):156-9 - PubMed
1. Intervirology. 1987;27(3):148-53 - PubMed
1. Mol Cell Biol. 1987 Aug;7(8):2745-52 - PubMed
1. J Biol Chem. 1988 Feb 15;263(5):2140-5 - PubMed

Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal - PubMed (original) (raw)